RecruitingNCT07077473

Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

A Retrospective Study Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases


Sponsor

Tongji Hospital

Enrollment

12 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world


Eligibility

Inclusion Criteria1

  • \- Clinical diagnosis of Familial Mediterranean fever (FMF) patients (Tel Hashomer criteria)

Exclusion Criteria3

  • Have a history of mental illness, or alcohol and drug dependence;
  • Pregnant, with severe infection, severe cardiac insufficiency, severe liver or kidney dysfunction;
  • Complicated with tumors, organ transplants, etc. which have significant impact on the immune system or require the use of immunosuppressants.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGreal word drugs

real word drugs


Locations(1)

Tongji Hospital

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07077473


Related Trials